Keith T. Flaherty Kinnate Biopharma Inc. (KNTE) insider trading activity

KNTE Quotes by TradingView

Keith T. Flaherty is of Kinnate Biopharma Inc.. Currently has a direct ownership of 0 shares of KNTE, which is worth approximately $0. The most recent transaction as insider was on Apr 03, 2024, when has been sold 66,377 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Keith T. Flaherty Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2024
SELL
Sale (or disposition) back to the issuer
-
66,377 Reduced 100.0%
0 Common Stock

Also insider at

CLVS
Clovis Oncology, Inc. Healthcare
Director
CMPI
Checkmate Pharmaceuticals, Inc.
Director
KTF

Keith T. Flaherty

Boulder, CO

Track Institutional and Insider Activities on KNTE

Follow Kinnate Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNTE shares.

Notify only if

Insider Trading

Get notified when an Kinnate Biopharma Inc. insider buys or sells KNTE shares.

Notify only if

News

Receive news related to Kinnate Biopharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNTE